Templeton, Arnoud J.

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

Armstrong, A. J., Lin, P., Higano, C. S., Sternberg, C. N., Sonpavde, G., Tombal, B., Templeton, A. J., Fizazi, K., Phung, D., Wong, E. K., et al. (2018) · Annals of Oncology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 71

Benefit and harms of new anti-cancer drugs

Vera-Badillo, F. E., Al-Mubarak, M., Templeton, A. J., & Amir, E. (2013) · Current Oncology Reports

Statistical Methods in Clinical TrialsHealth Systems, Economic Evaluations, Quality of Life

Cited by 35

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer

Ribnikar, D., Stukalin, I., Bedard, P. L., Hamilton, R. J., Jewett, M., Warde, P., Chung, P., Anson-Cartwright, L., Templeton, A. J., Amir, E., et al. (2020) · Current Oncology

Inflammatory Biomarkers in Disease PrognosisTesticular diseases and treatments

Cited by 15